Filing Details
- Accession Number:
- 0001387131-13-002105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-04 19:59:24
- Reporting Period:
- 2013-05-31
- Filing Date:
- 2013-06-04
- Accepted Time:
- 2013-06-04 19:59:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1420031 | Emmaus Life Sciences Inc. | NONE | Blank Checks (6770) | 412254389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1517691 | Yutaka Niihara | 20725 S. Western Ave Suite 136 Torrance CA 90501 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-05-31 | 470,000 | $0.00 | 9,999,711 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2013-05-31 | 450,000 | $0.00 | 9,549,711 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 44,229 | Indirect | As Custodian |
Footnotes
- The reporting person acquired the shares from the issuer in exchange for cancellation of promissory notes with an aggregate outstanding amount of principal and accrued interest of $1,551,000, equivalent to $3.30 per share of common stock acquired in the transaction.
- There was no cash exchanged for the common stock. The consideration provided was equity issued by an entity not affiliated with the issuer with a value equivalent to $3.30 per share of common stock disposed of in the transaction.
Billionaire Hedge Funds
